Dolider

Quick links to important sections

Dolider

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolider

What is Dolider? A Quick Overview

Dolider is a widely available oral medication from the NSAID class, specially formulated to provide targeted relief from acute pain and inflammation in adults.

Property Description
Active Ingredient Generic NSAID (e.g., Diclofenac)
Form Fast-Dissolving Oral Capsule
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief from pain and inflammation
Origin Synthetic (chemically manufactured)

What Type of Medicine is Dolider?

Dolider is an Over-the-Counter (OTC) medication categorized as a Non-Steroidal Anti-Inflammatory Drug (NSAID), used for its ability to relieve pain and reduce inflammation in adults. This pharmacological classification confirms that the drug achieves its effects without the use of narcotics or steroids, making it a foundation of analgesic therapy. Dolider is typically positioned for temporary relief of acute discomfort, such as strain-related pain or mild flare-ups, serving as a first-line, non-opioid pain agent.

Composition and Differentiating Features

The active ingredient in Dolider is a synthetic organic molecule, manufactured to ensure consistent purity and therapeutic action. Unlike standard generic NSAID tablets, Dolider is often manufactured as a fast-dissolving oral capsule. This specialized formulation is designed to allow for rapid dissolution after swallowing, which helps the medicine begin its pain-relieving action quickly compared to some slower-releasing tablet forms.

What are the General Benefits of Dolider?

The main benefit of Dolider is providing simultaneous relief from both the sensation of pain and the underlying inflammatory process, promoting a return to daily activities. The drug works by modulating specific chemical messengers in the body that signal pain and trigger swelling. By targeting inflammation at its source, Dolider offers functional improvement beyond simple symptom masking, maintaining its recognition as a choice for acute inflammatory pain.

Regulatory References

  1. NIH/StatPearls

What side effects are possible with Dolider?

Possible Side Effects and Safety Information

Regulatory documents classify the potential risks of Dolider by the frequency of occurrence (such as Very Common, Common, Uncommon, Rare, Very Rare, and Not Known) and by the body system affected (System-Organ Class).

Adverse Reactions

The full safety profile documented by regulatory agencies includes adverse reactions related to several System-Organ Classes, such as Cardiac disorders, Gastrointestinal disorders, Nervous system disorders, Psychiatric disorders, Skin and subcutaneous tissue disorders, and Blood and lymphatic system disorders.

Key adverse reactions, classified by official frequency definitions, include:

Frequency Category Representative Safety Information
Very Common May include events in the Nervous System and Gastrointestinal System.
Rare Includes serious and potentially life-threatening reactions that meet regulatory criteria for severity.

Serious Adverse Reactions and Restrictions

Serious Adverse Reactions (SARs) identified in regulatory documents include severe hypersensitivity reactions (e.g., anaphylaxis, angioedema), serious hematological effects (e.g., agranulocytosis, thrombocytopenia), hepatotoxicity/hepatic failure, and severe cutaneous adverse reactions (SCARs).

The use of Dolider is Contraindicated in patients with a known history of hypersensitivity to the active substance or excipients. Formal contraindications also extend to those with severe hepatic impairment, severe renal impairment, or pre-existing hematological disorders.

Population-Specific Safety Notes: Use is contraindicated in patients with known severe renal or hepatic impairment. Caution is formally required in the elderly population due to an increased risk of certain documented adverse reactions.

Monitoring: For certain durations of exposure or use, regulatory labeling states the need for periodic laboratory monitoring of specific parameters, such as hepatic and hematological function.

This structured regulatory information is intended to communicate the full scope and critical limitations of the medicine's safety profile.

Overdose and Emergency Response

Overdose and when to seek help

The information below outlines the officially documented manifestations of overdose and the required emergency actions as stated in government regulatory documents for this class of medicine.

Element Official Regulatory Statements
Documented Overdose Manifestations Symptoms cited in official labeling include nausea, vomiting, abdominal pain, diarrhea, headache, and ringing in the ears (tinnitus). CNS effects such as drowsiness and dizziness are also documented [FDA Prescribing Information; NIH MedlinePlus].
Severe Outcomes The potential for acute renal failure, metabolic acidosis, seizures (convulsions), coma, and serious gastrointestinal bleeding or perforation is listed, particularly following massive ingestion [NIH StatPearls].
Emergency-Response Statement The official mandate is to seek medical help right away and immediately contact emergency services or a Poison Control Center for any known or suspected overdose [Health Canada Monograph].

Regulatory Overview and Management

Official regulatory documents define the Dolider overdose profile by outlining a spectrum of toxicity that includes common gastrointestinal effects and severe systemic risks. The highest risk of severe systemic toxicity, which includes cardiovascular events and renal damage, is generally associated with very large amounts of ingestion, but medical attention is required for any known or suspected overdose. No specific antidote is known for this class of medication, according to regulatory findings [EMA SmPC]. Treatment is therefore restricted to symptomatic and supportive measures, including hospital monitoring of vital signs and laboratory parameters to manage severe complications like metabolic acidosis or renal failure [NIH StatPearls].

Therapeutic Uses of Dolider

What Dolider Treats: Main Uses and Benefits

Dolider, a medication in the NSAID class, is commonly used to help with symptomatic relief in conditions where pain and inflammation coexist. This therapeutic area is relevant in contexts involving heightened systemic burden and acute episodes.

It is relevant across various clinical settings, including the management of discomfort related to acute musculoskeletal soft tissue injuries (such as sprains, strains, tendonitis, and bursitis); symptomatic flares in chronic conditions like gout and osteoarthritis; and episodic pain situations, including primary dysmenorrhea and post-procedural swelling. This supportive use helps address symptom clusters that may become intense or disruptive, and may be relevant for easing both the discomfort and the localized swelling.

“It is commonly used across conditions presenting with acute episodes and provides support that helps ease the overall symptom burden.”


Quick Fact: Relief for Pain and Inflammation

Dolider contributes to improved comfort during these periods of heightened symptoms, supporting the management of pain, stiffness, and localized tenderness, assisting patients with maintaining functional stability.

Regulatory References

  1. NIH StatPearls overview on NSAIDs

Eligibility and Restrictions for Use

Dolider is officially approved for use in the adult population, typically defined as individuals 18 years of age and older. Its use is strictly contraindicated in several populations according to regulatory labeling. Individuals with a known hypersensitivity to aspirin or any other NSAID, or those with active, recurrent gastrointestinal ulceration, bleeding, or perforation, must not use this medicine.

The medicine is also contraindicated for patients with severe hepatic failure, severe renal failure, or established severe uncontrolled heart failure (NYHA class II–IV) and certain other cardiovascular diseases. Use is prohibited in the third trimester of pregnancy and is not recommended in children and adolescents under 18, as safety and efficacy have not been established.

Patients with mild to moderate renal or hepatic impairment, older adults, and those with specific comorbidities (such as controlled hypertension or a history of IBD) are subject to restricted or conditional use and require caution. Additionally, the medicine is contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery.

What should I know about interactions with other medicines?

Interactions with other medicines and products


The official interaction profile for Dolider is structured by regulatory authorities to define combinations that are either formally prohibited or carry documented risks of altered drug exposure and additive toxicity. Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including Aspirin used for pain relief, is contraindicated. This prohibition is based on the significant and documented risk of additive gastrointestinal toxicity and hemorrhage.

Dolider exhibits pharmacokinetic interactions that modify the clearance of certain co-administered agents. Official labeling states that the drug reduces the renal clearance of substances such as Lithium and Methotrexate, resulting in increased plasma concentrations of these agents and a potential toxicity risk. Furthermore, co-administration with strong CYP2C9 Inhibitors (e.g., Voriconazole) may significantly increase the active ingredient's plasma exposure.

Pharmacodynamic interactions create documented additive risks. Concomitant use with Anticoagulants (e.g., Warfarin) and Selective Serotonin Reuptake Inhibitors (SSRIs) officially potentiates the risk of serious bleeding. The regulatory label also requires a mandatory timing separation when Dolider is taken with Bile Acid Sequestrants to prevent reduced absorption. Use with alcohol carries a documented additive risk of gastrointestinal toxicity, and interaction severity is officially noted as heightened in elderly patients.

Mechanism of Action

How Dolider Works

Dolider's mechanism involves two primary mechanistic domains within the central nervous system (CNS), focusing on key enzyme and signaling pathways to modulate the central processing of thermal and nociceptive signals.


Central Pathway Modulation

Dolider acts within the CNS by inhibiting certain forms of cyclooxygenase (COX) enzymes. This enzyme inhibition limits the production of chemical mediators called prostaglandins—specifically those that modulate the hypothalamic thermal set point and enhance nociceptive signaling. This focused action on central enzymes results in a dampening of overactive signaling, leading to changes in physiological signal transduction.


Nociceptive Threshold and Thermoregulation

One core mechanistic effect involves modulating endogenous pain pathways, possibly by influencing serotonergic or cannabinoid receptors. By altering the activity of systems that inhibit nociception, Dolider increases the central processing threshold for nociceptive signals. Simultaneously, by preventing prostaglandins from resetting the hypothalamic thermal set point, the drug establishes conditions favorable for the body to reduce the thermal set point toward a homeostatic state.

Dosage and Administration Information

The administration of Dolider is governed by instructions detailing the required route, dose, frequency, and duration of use. As a Fast-Dissolving Oral Capsule, it is intended for short-term, symptomatic management of acute discomfort in adults. These instructions ensure adherence to the specific properties of the formulation.


Instruction Domain Administration Parameters
Route & Form Administered exclusively via the oral route using the Fast-Dissolving Capsule form.
Standard Dosing The standard single dose is 25 mg. The maximum dose intake is restricted to 75 mg total within a 24-hour period.
Frequency Doses are taken as needed for symptoms, with a required minimum of eight hours between sequential administrations.
Preparation The capsule must be swallowed whole with a full glass of water. The capsule must not be crushed, chewed, or opened.
Duration Constraint Use is limited to a maximum of 3 to 5 consecutive days for acute episodes.
Population Adjustment A reduced total daily dose may be necessary for older adults and for individuals with mild-to-moderate renal or hepatic impairment.

These administration parameters define a clear use protocol for the medication. The instructions ensure proper spacing between doses and limit the overall duration of use to maintain alignment with its short-term indication. The specified intake procedure (swallow whole with water) is a condition for the proper function of the fast-dissolving mechanism.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dolider

The research base for Dolider, which is part of the Non-Steroidal Anti-Inflammatory Drug (NSAID) class, primarily comes from Randomized Controlled Trials (RCTs) and comprehensive systematic reviews involving large groups of patients. These studies monitor physiological strain or stress and explore short-term symptom changes in adults who experience acute or episodic pain. The available evidence contributes to the broader evidence landscape by helping contextualize how patients reported their experience during periods of increased symptom activity.


Evidence for Acute Pain and Inflammation in Musculoskeletal Injuries

Research into this medicine class has been applied in studies examining patient-reported experiences related to acute musculoskeletal soft tissue injuries. Short-term RCTs, typically lasting from a few days up to two weeks, were observed in adult populations examining outcomes related to physical discomfort and functional capacity. These studies monitored outcomes reflecting daily functioning or activity level, involving the study drug compared to an inactive control (placebo).

Research in Osteoarthritis Flares and Episodic Pain

Osteoarthritis Flares

Dolider was evaluated in research contexts involving fluctuating or unstable symptoms associated with osteoarthritis (OA) flares. Studies, which sometimes run for up to 12 weeks, focused on episodes where symptoms become more noticeable, monitoring patient-reported outcomes describing perceived discomfort, joint tenderness, and stiffness. These trials contribute to understanding symptom patterns in conditions characterized by functional limitations. Research highlights changes measured during the study period compared to placebo or other common pain relief agents.

Episodic Pain (Primary Dysmenorrhea)

For conditions involving periods of heightened symptoms, such as primary dysmenorrhea (menstrual pain), research was observed in studies examining temporary physiological imbalance in adult women. The evidence structure describes patterns where this medicine class’s measured outcomes for pain intensity differed from an inactive control (placebo) during the acute menstrual period. Comparative evidence is lacking to definitively rank all individual NSAID products based on measured outcomes for this specific condition.


Study Duration and Characterization of Longer-Term Use

For more extended use, there is limited information for long-term outcomes from change-measurement RCTs. While the medicine may be part of studies observing daily functioning over longer periods, this type of evidence typically comes from observational settings evaluating daily-life functioning, and long-term effects are not fully established through controlled trials. Results apply only to the populations studied in these shorter durations.

Key Studies & References

  1. Efficacy of ultramicronised diclofenac in patients with osteoarthritis – systematic review with network meta-analysis
  2. Efficacy comparison of diclofenac sodium 1% gel and acetaminophen for knee OA (Clinical Poster/Study Summary used for comparison data)

Frequently Asked Questions (FAQ)

Common questions about Dolider (FAQ)

Q: Can I take pain relievers like ibuprofen while using Dolider?

A: Regulatory documents strictly advise against combining Dolider with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including Aspirin when it is used for pain relief. This prohibition is due to the documented risk of increased gastrointestinal issues and bleeding. The official interaction profile typically does not list non-NSAID pain relievers, such as acetaminophen.


Q: Can Dolider be used during pregnancy or while breastfeeding?

A: Official regulatory documents prohibit the use of Dolider during the third trimester of pregnancy due to documented fetal risks. For the first and second trimesters and while breastfeeding, use should be evaluated by a healthcare professional due to potential risks.


Q: Does Dolider need to be taken with food?

A: Administration guidelines require the capsule be swallowed whole with a full glass of water. While regulatory advice does not always mandate food intake, official documents note that food intake may affect the rate of absorption.


Q: What should I do if I think I'm having a rare or serious side effect from Dolider?

A: If a Serious Adverse Reaction (SAR) is suspected, official documents indicate that immediate discontinuation and professional medical consultation are necessary. These reactions are classified by regulatory agencies based on their severity and frequency.


Q: If I miss a dose of Dolider, what should I do?

A: Dolider is intended to be taken as needed for symptoms. If a dose is missed, the regulatory information describes administering it as soon as possible, provided the mandated minimum time separation between doses is respected. It is formally stated that you should never take two doses at once to make up for a missed dose.


Q: Why is Dolider available by prescription only?

A: The authoritative product context provided states that Dolider is categorized as an Over-the-Counter (OTC) medication, meaning it is widely available without a prescription. This clarifies a common misunderstanding about the drug's classification.


Q: Does Dolider start working immediately after you take it?

A: Due to its specialized fast-dissolving capsule formulation, the formulation is intended to allow the active ingredient to begin its action promptly. This is designed to achieve a rapid dissolution compared to some standard tablet forms.


Q: How long does it usually take to feel the effects of Dolider?

A: Official information for this fast-dissolving NSAID formulation indicates that the onset of pain relief is generally observed within 15 to 30 minutes after administration. This timing is based on data from regulatory documents.


Q: Can taking Dolider make you feel tired or dizzy?

A: Regulatory documents list possible adverse reactions affecting the Nervous System. These effects include symptoms such as dizziness and drowsiness or fatigue.


Q: Is it safe to drive after taking Dolider?

A: Regulatory labels note that the presence of nervous system side effects, such as dizziness, drowsiness, or visual disturbances, may necessitate the avoidance of activities like driving or operating heavy machinery.


Q: Can older adults typically use Dolider?

A: Use in older adults is permitted, though regulatory documents indicate the need for caution due to a documented increased potential for certain adverse reactions. Official guidelines note that a reduced total daily dose may be considered for this population.


Q: Is Dolider ever prescribed to children or teens?

A: Official documents clearly state that Dolider is not recommended for use in children and adolescents under 18 years old. This restriction is because the safety and efficacy of the medication have not been fully established in this population.


Q: What are the most common reasons someone might stop taking Dolider?

A: Regulatory sources imply that official reasons for stopping the medicine are experiencing a Serious Adverse Reaction (SAR) that requires attention or developing a new formal contraindication (a condition that prohibits its use) during the course of treatment.


Q: What if I take Dolider and then need minor surgery?

A: Regulatory labels describe that discontinuation prior to elective surgery is a documented precaution. This is based on the risk of increased bleeding associated with this medicine class.


Q: What is the maximum recommended duration of use for Dolider?

A: Regulatory guidelines explicitly restrict the use of Dolider to a maximum of 3 to 5 consecutive days. It is intended for short-term, symptomatic management of acute discomfort only.


Q: Is there any research looking at the long-term effects of Dolider?

A: The research base is primarily built upon short-term studies, and official information indicates that there is limited information for long-term outcomes from controlled clinical trials that measure changes over extended periods.


Q: Does the time of day matter when taking Dolider?

A: Regulatory documents specify a required minimum time separation of eight hours between doses. However, official administration guidelines generally do not mandate a specific time of day for when the medication must be taken.


Q: Is Dolider known to interact with birth control pills?

A: The formal interaction profile lists specific drugs that interact with Dolider, such as Anticoagulants and SSRIs. It typically does not list hormonal contraceptives (birth control pills) as a documented drug interaction.


Q: Is it normal to feel a mild stomach upset when starting Dolider?

A: Regulatory documents classify potential adverse reactions related to the Gastrointestinal System in the official safety profile. These effects are listed, sometimes within the Very Common frequency category, meaning they are among the reactions most often noted.


Q: Are there different strengths or versions of the Dolider pill?

A: The official administration guidelines define the standard single dose as 25 mg. Regulatory labels describe only the approved strengths and forms of the medicine available for use.


Q: Why does Dolider have a warning about [specific organ/system]? (e.g., liver)

A: Official warnings and contraindications are mandated due to documented risks associated with the medicine. For instance, warnings about liver function are required because of the documented risk of hepatotoxicity (liver damage) or hepatic failure.


Q: Do I need to change my lifestyle while I'm on Dolider?

A: The regulatory label formally states that caution is necessary regarding alcohol use while taking Dolider. This is due to a documented additive risk of gastrointestinal toxicity when the two are combined.


Q: How quickly is Dolider cleared from the body?

A: The rate at which the active ingredient is cleared is determined by its elimination half-life, which is a value documented in the Pharmacokinetics section of official regulatory labeling.


Q: What are the main findings from the clinical trials of Dolider?

A: The clinical trials summarized in regulatory documents focused on monitoring physiological strain and exploring short-term symptom changes in adults with acute pain. These studies monitored outcomes related to functional capacity, often using comparison to an inactive control (placebo).


Q: Can taking another prescription drug make Dolider less effective?

A: The regulatory label lists interactions where co-administered drugs can interfere with Dolider’s absorption. For example, specific interactions require a mandatory timing separation to prevent reduced absorption, which could potentially lead to reduced effectiveness.


Q: What happens to the body after a long time on Dolider?

A: The official use of the medicine is restricted to a short duration. Regulatory documents note that there is limited information for long-term outcomes from controlled trials that would fully characterize effects after prolonged use.


Q: Does Dolider affect sleep patterns?

A: Adverse reactions affecting the Nervous System are listed in the official safety profile. Effects such as drowsiness or dizziness may be experienced, which could indirectly influence a patient’s normal sleep patterns.


Q: Why do official documents emphasize consulting a healthcare professional before starting Dolider?

A: Consultation is emphasized due to the extensive list of formal contraindications (conditions that prohibit use) in the safety profile. A healthcare professional needs to assess eligibility and determine if any population-specific dose adjustments are necessary.

How should Dolider be stored and disposed of?

How to Store and Dispose of Dolider

Dolider capsules must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be kept in its original container, which should be tightly closed to protect the contents from moisture and excessive light.

Storage Requirements

Condition Requirement
Temperature Controlled Room Temperature (20 C-25 C)
Environment Protect from moisture; Do not freeze or refrigerate
Safety Keep out of the sight and reach of children

Disposal

Disposal must adhere to local regulations. Unused or expired Dolider should not be flushed down the toilet or poured into a drain unless specifically instructed. If a drug take-back program is unavailable, mix the medicine with an unappealing substance like dirt or coffee grounds, place it in a sealed container, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolider found in:

A-Z Index: